Unlock instant, AI-driven research and patent intelligence for your innovation.

TGF-beta trap

A TGF-, trap technology, applied in the field of TGF-β trap, can solve the problems of loss of immune regulation, increased inflammatory response, decreased wound healing, etc.

Pending Publication Date: 2022-04-26
NANTBIO INC
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies using knockout mice have shown that systemic loss of TGF-β function can lead to reduced wound healing, loss of immune regulation and increased inflammatory responses

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • TGF-beta trap
  • TGF-beta trap
  • TGF-beta trap

Examples

Experimental program
Comparison scheme
Effect test

example

[0119] Materials and methods:

[0120] TGF-β reporter cell line. TGF-β-responsive stable cell lines were created by transfecting HEK-293T cells with pGL4.28 (Promega), a TGF-β-responsive element containing Driven luciferase expression plasmid. Transfected cells were selected using hygromycin for two months.

[0121] transfection. TGF-β trap constructs were transiently transfected into the TGF-β reporter 293T cell line with Lipofectamine (Thermo Fisher) using the recommended protocol followed by overnight incubation. These cells were then stimulated for 18 hours with TGF-β1, TGF-β2 or mouse TGF-β1 (Cell Signaling Technology) at the concentrations indicated in the figures. Following stimulation, responses were measured using the Luciferase Assay System (Promega) according to the recommended protocol.

[0122] IgG titer measurement:TGF-β Trap IgG fusion titers were measured using a Protein A biosensor on a ForteBio Octet Red96 instrument. HEK-293T cells were transfected...

example 1

[0123] Example 1: Inhibition of TGF-β Responses by Constitutively Active TGF-β Trap Constructs

[0124] 293T cell line stably expressing TGF-β-inducible luciferase was transfected with a CMV-driven expression construct comparing Sushi domain (Sushi), unmodified hinge (AltH), with or without TGFBRII (SNAP) Fc domain (Fc) of Fc with modified hinge ((C27S)H), Fc with or without TGFBRII (trap) (SEQ ID NO: 15, 17, 19 and 21; with corresponding SEQ ID NO : DNA sequences of 14, 16, 18 and 20). Cells were incubated overnight, washed and stimulated with TGF-β at the indicated concentrations. The resulting luciferase activity was measured after 18 hours. Figure 1A with 1B The data shown in indicate that these trap constructs inhibit TGF-β at low levels (0-1 ng / ml), but only constructs with modified hinges are effective at high concentrations.

example 2

[0125] Example 2: Inhibition of TGF-β Responses by TGF-β Inducible Trap Constructs

[0126] A 293T cell line stably expressing TGF-β-induced luciferase was transfected with a TGF-β-responsive element (TGFBRE)-driven expression construct to compare Sushi domain (Sushi), unmodified hinge (AltH), with or Fc domain (Fc) without TGFBRII (trap) compared to modified hinge ((C27S)H), Fc with or without TGFBRII (trap) (SEQ ID NO: 7, 9, 11 and 13; DNA sequences having corresponding SEQ ID NO: 6, 8, 10 and 12). Cells were incubated overnight, washed and stimulated with TGF-β at the indicated concentrations. The resulting luciferase activity was measured after 18 hours and the data are shown in Figure 2A with 2B middle. The original construct was unable to block TGF-β activity in an inducible form, whereas the modified construct was effective at low concentrations (0.1ng / ml) and still exhibited neutralization at moderate to high concentrations (1-10ng / ml) active.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Compositions and methods for inhibiting TGF-beta are provided. Trap molecules are provided in which a ligand binding domain of a Type 2 transforming growth factor-beta receptor (TGF [beta] RII) is fused to an immunoglobulin Fc domain containing an N-terminal immunoglobulin hinge region in which at least one unpaired cysteine residue of the hinge region is replaced with a serine residue.

Description

[0001] cross reference [0002] This application claims the benefit of U.S. Provisional Patent Application No. 62 / 887,272, filed August 15, 2019, which is hereby incorporated by reference in its entirety. [0003] References to Sequence Listings [0004] This application contains a Sequence Listing filed as an electronic text file named "8774-14-PCT_Seq_Listing_ST25.txt", which is 68 bytes in size and was created on August 14, 2020. Pursuant to 37 CFR §1.52(e)(5), the information contained in this electronic document is hereby incorporated by reference in its entirety. technical field [0005] Compositions and methods for inhibiting transforming growth factor beta (TGF-beta) activity are provided. Background technique [0006] TGF-β is a family of multifunctional cytokines involved in cell proliferation and differentiation, embryonic development, extracellular matrix formation, skeletal development, wound healing, hematopoiesis, and immune and inflammatory responses. TGF-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C12N15/62A61K38/17A61K47/68A61P35/00
CPCC07K16/22C07K14/71A61K38/179A61K47/6811A61P35/00C07K2317/53C07K2317/76C07K2317/90C07K2319/00C07K2319/30C12N5/0646C12N2510/00A61K9/0019
Inventor P·刘W·希加施德C·A·奥尔森K·尼亚兹
Owner NANTBIO INC